FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
2,253 letters match. Newest first.
-
DrugsThomas Brunner Hygiene GmbH
Thomas Brunner Hygiene GmbH's syNeo antiperspirants are unapproved new drugs and were made without adequate manufacturing testing and validation.
High risk -
FoodVasoCorp, Inc.
FDA says VasoCorp markets NeuropAWAY supplements as unapproved drugs with disease-treatment claims.
High risk -
Tobaccomkpodplug.co.uk
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsIsland Kinetics, Inc. d.b.a. CoValence Laboratories
Island Kinetics (CoValence Laboratories) made OTC acne drugs without process validation and shipped unapproved, misbranded acne products.
High risk -
DrugsBioMylz Pvt. Ltd.
FDA found destroyed records, inadequate process and cleaning validation, missing microbial testing, and incomplete drug listings at BioMylz, an Indian OTC drug manufacturer.
High risk -
Tobaccoejuicedemand.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccoindejuicevapestore.co.uk
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodMineral BioSciences, LLC
Mineral BioSciences’ Totala and Ionicell supplements were flagged as unapproved new drugs and misbranded, with manufacturing violations.
High risk -
Tobaccoeliquidflavourconcentrates.co.uk
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccosnusblast.co.uk
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DevicesNihon Kohden Digital Health Solutions, LLC
FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.
High risk -
FoodNutratech, LLC
FDA cited Nutratech, LLC for manufacturing violations and an undeclared allergen in dietary supplements.
High risk -
DrugsKetacyn Pharmaceuticals / www.ketacynpharma.com
FDA told Ketacyn Pharmaceuticals to stop selling unapproved ketamine injection and ketamine gummies to U.S. consumers online.
High risk -
DrugsExtra Medication / www.extramedication.com
FDA warned website Extra Medication for selling unapproved, misbranded ketamine drugs to U.S. consumers without prescriptions.
High risk -
DrugsPure Arylcyclohexylamine Store / www.arylcyclohexylamine.com
FDA warned Pure Arylcyclohexylamine Store it sells unapproved, misbranded ketamine drugs, including an injectable, to U.S. consumers online.
High risk -
DrugsAll Ketamine HCL / www.allketaminehcl.com
FDA warned website All Ketamine HCL for selling unapproved, misbranded ketamine drugs online without prescriptions.
High risk -
DrugsKetamine Troche Store / www.ketaminetrochestore.com
FDA warned online seller Ketamine Troche Store that its website sells unapproved, misbranded ketamine drugs without prescriptions.
High risk -
DrugsBuy Keta Online / www.buyketaonline.com
FDA warns Buy Keta Online that its website sells unapproved and misbranded ketamine drugs to U.S. consumers.
High risk -
DrugsKetamine Store / www.ketaminestore.org
FDA warned website Ketamine Store for selling unapproved, misbranded ketamine liquid and compounded products online without prescriptions.
High risk -
DrugsLegit Ketamine Suppliers / www.legitketaminesuppliers.com
FDA warns Legit Ketamine Suppliers website for selling unapproved, misbranded ketamine and esketamine drugs to U.S. consumers.
High risk -
DrugsKetdaxandrugs / www.ketdaxandrugs.org
FDA warned Ketdaxandrugs it sells unapproved, misbranded ketamine "KETAMINE CRYSTAL" online without prescriptions to U.S. consumers.
High risk -
Drugsketaminetroches.com
FDA warns ketaminetroches.com that it sells unapproved and misbranded ketamine troches to U.S. consumers online.
High risk -
DrugsMed Shop Inc / www.medshopinc.com
FDA warned Med Shop Inc that its website sells unapproved, misbranded ketamine nasal spray to U.S. consumers.
High risk -
DrugsLyfeUnit / www.lyfeunit.com
FDA warns LyfeUnit website for selling unapproved, misbranded ketamine vials to U.S. consumers.
High risk -
DrugsKeta Med Lab / www.ketamedlab.com
Keta Med Lab's website sold unapproved, misbranded ketamine liquid, troches and nasal spray to U.S. consumers without prescriptions, FDA says.
High risk -
DrugsKet Plug / ketaminelab.org and buyketaminepowderonline.com
FDA warns Ket Plug that its ketamine websites sell unapproved, misbranded ketamine powder to U.S. consumers.
High risk -
DevicesBlephEx, LLC
FDA says BlephEx sold three eye devices without required FDA clearance and missed device reports.
High risk -
DevicesSkytron, LLC
Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.
High risk -
DevicesBMC Medical Co., Ltd.
BMC Medical’s G3X APAP devices were misbranded/adulterated after significant changes without a new 510(k) and an unreported firmware fix.
High risk -
DrugsAmazon.com, Inc.
FDA warned Amazon that three creams sold and shipped through Fulfillment by Amazon are unapproved new drugs for phimosis and balanitis.
High risk -
DrugsGreat India Overseas Pvt. Ltd. dba Silkrute
FDA warns Silkrute over unapproved new drugs sold on its website, including ProGlan, Cordiagra, and Prost Aid.
High risk -
DrugsLeading Edge Health Inc.
FDA told Leading Edge Health its Erectin Stimulating Gel and VigRX Delay Wipes are unapproved new drugs based on claims on its website.
Medium -
DrugsIndiangoods.shop
FDA warned website Indiangoods.shop that three herbal sexual-performance capsules it sells are unapproved new drugs.
Medium -
DrugsWild Arabic Herbs
FDA warns Wild Arabic Herbs that its website sells Edral-17t as an unapproved drug for prostate and testicular cancers.
High risk -
DrugsHerbal Dermals LLC FZ dba Gotucream
FDA warned Herbal Dermals LLC FZ dba Gotucream that its Gotucream balanitis cream is an unapproved new drug.
Low -
DrugsJJLBRO
JJLBRO and Romvy E-Ticaret sold five male creams and sprays as unapproved new drugs on a website and Amazon.
High risk -
DrugsTelos Trading Limited dba Alwinshop
FDA warns UK online seller Alwinshop that its "Prostatitis Remission Cream" is an unapproved, misbranded drug with false FDA endorsement claims.
High risk -
DrugsMantroForce
MantroForce marketed five sexual-health and prostate products as unapproved new drugs, FDA says.
High risk -
DrugsWholesale Peptide
FDA warns Wholesale Peptide that its website sells Prostamax and Gonadorelin as unapproved new drugs.
High risk -
DrugsTexinkart Inc.
Texinkart Inc. sold four Ayurvedic products online without FDA drug approval, FDA says.
High risk -
FoodImu-Tek Animal Health, Incorporated
FDA warns Imu-Tek Animal Health over unapproved drug claims and manufacturing failures for Colostrom-5 products.
High risk -
DrugsNativeMed LLC dba NativeMed
FDA warned telehealth seller NativeMed that its website misbranded compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsHydraMed IV LLC dba HydraMed
FDA told Denver telehealth seller HydraMed its website misbrands compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsNexus Health Solutions LLC dba Harper Meds
FDA warned telehealth seller Harper Meds that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.
Low -
DrugsFitRX, LLC dba AM RX
FDA warned telehealth seller AM RX that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.
Medium -
DrugsAltru Telehealth, LLC dba Altru Telehealth
FDA warns Altru Telehealth that its website falsely claimed compounded semaglutide/tirzepatide and compounding pharmacies were FDA-approved.
Low -
DrugsEden Health International Inc. dba Eden
FDA warned Eden Health International that its telehealth website misbrands compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsTrinity HealthCare Supply, LLC dba altRx
FDA warns altRx over misleading website claims for compounded semaglutide and tirzepatide, including 'clinically proven' and wrong compounder label.
Low -
DrugsAmie Health, Inc. dba Amie
FDA warned telehealth seller Amie Health that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.
Medium -
DrugsThrivelab Co. dba Thrivelab
FDA warned telehealth seller Thrivelab that its website misbrands compounded semaglutide with false claims suggesting FDA approval.
Medium